These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 16188440

  • 1. Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.
    Kara IO, Sahin B, Erkisi M.
    Breast; 2006 Jun; 15(3):414-24. PubMed ID: 16188440
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia.
    Chalermchai T, Tantiphlachiva K, Suwanrusme H, Voravud N, Sriuranpong V.
    Asia Pac J Clin Oncol; 2010 Sep; 6(3):155-60. PubMed ID: 20887495
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.
    Mrozek E, Ramaswamy B, Young D, Rhoades CA, Kendra K, Allen J, Moore T, Hauger M, Watson H, Merriman N, Nadella P, Villalona-Calero M, Shapiro CL.
    Clin Breast Cancer; 2006 Jun; 7(2):141-5. PubMed ID: 16800973
    [Abstract] [Full Text] [Related]

  • 7. [Plantar-palmar erythrodysesthesia. A new and relatively frequent side effect in antineoplastic treatment].
    Risum S, Langer SW.
    Ugeskr Laeger; 2003 Aug 11; 165(33):3161-2. PubMed ID: 12968412
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Is pyridoxine helpful in preventing palmar-plantar erythrodysesthesia associated with capecitabine?
    Jeung HC, Chung HC.
    Asia Pac J Clin Oncol; 2010 Sep 11; 6(3):141-3. PubMed ID: 20887492
    [No Abstract] [Full Text] [Related]

  • 11. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D, Alessandroni P, Catalano V, Giordani P, Fedeli SL, Fedeli A, Baldelli AM, Casadei V, Ceccolini M, Catalano G.
    Clin Breast Cancer; 2007 Dec 11; 7(11):857-60. PubMed ID: 18269775
    [Abstract] [Full Text] [Related]

  • 12. A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancer.
    Lebowitz PF, Eng-Wong J, Swain SM, Berman A, Merino MJ, Chow CK, Venzon D, Zia F, Danforth D, Liu E, Zujewski J.
    Clin Cancer Res; 2004 Oct 15; 10(20):6764-9. PubMed ID: 15501952
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Topical DMSO treatment for pegylated liposomal doxorubicin-induced palmar-plantar erythrodysesthesia.
    Lopez AM, Wallace L, Dorr RT, Koff M, Hersh EM, Alberts DS.
    Cancer Chemother Pharmacol; 1999 Oct 15; 44(4):303-6. PubMed ID: 10447577
    [Abstract] [Full Text] [Related]

  • 15. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer.
    Blum JL, Dees EC, Chacko A, Doane L, Ethirajan S, Hopkins J, McMahon R, Merten S, Negron A, Neubauer M, Ilegbodu D, Boehm KA, Asmar L, O'Shaughnessy JA.
    J Clin Oncol; 2006 Sep 20; 24(27):4384-90. PubMed ID: 16926223
    [Abstract] [Full Text] [Related]

  • 16. Single-agent capecitabine maintenance therapy after response to capecitabine-based combination chemotherapy in patients with metastatic breast cancer.
    Huang H, Jiang Z, Wang T, Zhang S, Bian L, Cao Y, Wu S, Song S.
    Anticancer Drugs; 2012 Aug 20; 23(7):718-23. PubMed ID: 22739713
    [Abstract] [Full Text] [Related]

  • 17. Gemcitabine plus docetaxel: a new treatment option for anthracycline pretreated metastatic breast cancer patients?
    Levy C, Fumoleau P.
    Cancer Treat Rev; 2005 Aug 20; 31 Suppl 4():S17-22. PubMed ID: 16360543
    [Abstract] [Full Text] [Related]

  • 18. Low-dose capecitabine plus docetaxel as first-line therapy for metastatic breast cancer: phase II results.
    Michalaki V, Gennatas S, Gennatas K.
    Anticancer Drugs; 2009 Mar 20; 20(3):204-7. PubMed ID: 19174694
    [Abstract] [Full Text] [Related]

  • 19. The evolving role of capecitabine in breast cancer.
    O'Shaughnessy JA.
    Clin Breast Cancer; 2003 Apr 20; 4 Suppl 1():S20-5. PubMed ID: 12756075
    [Abstract] [Full Text] [Related]

  • 20. Phase I study of 3-weekly docetaxel, capecitabine and oxaliplatin combination chemotherapy in patients with previously untreated advanced gastric cancer.
    Sym SJ, Ryu MH, Kang HJ, Lee SS, Chang HM, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK.
    Cancer Chemother Pharmacol; 2010 Jul 20; 66(2):373-80. PubMed ID: 19936751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.